One Stop Solution For In-Depth Market Research Reports


Home    >    HEALTHCARE AND PHARMACEUTICALS   >   Gynecological Devices Market

[ 英語タイトル ] Gynecological Devices Market - Growth, Trends, and Forecast (2020 - 2025)

Product Code : MDHC0082619
Survey : Mordor Intelligence
Publish On : November, 2020
Category : Healthcare and Pharmaceuticals
Report format : PDF
Sales price option (consumption tax not included)
Single User USD4250 / Question Form
5 User USD4750 / Question Form
Enterprise User USD7500 / Question Form
 - Boston Scientific Corporation
- Hologic, Inc.
- Johnson & Johnson
- Karl Storz SE & Co. KG
- Medtronic PLC
- Olympus Corporation
- Richard Wolf GmbH
- Stryker Corporation
- The Cooper Companies, Inc.

[Report Description]

An increase in gynecological disorders, such as ovarian cancer, cervical cancer, uterine cancer, vaginal and vulvar cancer are driving the market for gynecological devices across the world. The American Cancer Society states that the average age of endometrial cancer diagnosis in women is 60, whereas it isn’t common amongst women below the age of 45. In addition, WHO suggests a routine endometrial ablation procedure should be performed for women above the age of 35, in order to avoid the risks associated with endometrial cancer. Obesity, diabetes, and PCOS patients are more susceptible to endometrial cancer at the ages of 18 to 35 and require endometrial biopsy. The World Health Organization has stated that approximately, 90% of deaths from cervical cancer occur in low- and middle-income countries. The high mortality rate from cancer could be reduced through a comprehensive approach that includes prevention, early diagnosis, effective screening and treatment programs. This, in turn, leads to high demand for gynecological devices globally.

Key Market Trends

Endometrial Ablation Devices Segment is Expected to Show Better Growth in the Forecast Years

Based on Product Type, the market is segmented into Gynecological Endoscopy Devices, Endometrial Ablation Devices, Contraceptive Devices, Diagnostic Imaging Systems, Fluid Management Systems, and Others.

The growth of the endometrial ablation devices segment is mainly attributed to the rising burden of cancer and the rising adoption of these devices due to their ease of use and convenience. Endometrial ablation is a type of minimally invasive procedure for the treatment of heavy menstrual bleeding. In addition, endometrial ablation offers several advantages over the other surgeries such as shorter procedure time, faster recovery, and lower pain. Hence, owing to the aforementioned factors, along with the rising adoption of endometrial ablation devices, the segment is expected to witness rapid growth over the forecast period.

North America holds the Largest Share in the Gynecological Devices Market

The North America region holds the largest share of the market studied due to the increasing burden of cancer, the strong presence of device manufacturers, and technological advancements. According to the American Cancer Society, in 2019, an estimated 1,762,450 new cancer cases were diagnosed in the United States. Among all the cancers, there is a major concern for cervical cancer which is growing rapidly in American women. This rising number of cancer is augmentin the demand for the gynecology devices across the country. Additionally, other factors such as rising awareness among women, increasing prevalence of gynecological disorders and well-established healthcare infrastructure are expected to drive the market growth in the forecast period.

Competitive Landscape

The market studied is moderately competitive and there are several global companies that are operating in this market. The major players in the gynecological devices market are Boston Scientific Corporation, Hologic Inc, Johnson & Johnson, Karl Storz SE & Co. KG, Medtronic PLC, Olympus Corporation, Richard Wolf GmbH, Stryker Corporation and The Cooper Companies, Inc

Reasons to Purchase this report:

- The market estimate (ME) sheet in Excel format
- 3 months of analyst support

1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study



4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Prevalence of Gynecological Disorders
4.2.2 Growing Public Awareness
4.2.3 Rise in Surgical Procedures
4.3 Market Restraints
4.3.1 Stringent Regulatory Guidelines
4.4 Porter's Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry

5.1 By Product Type
5.1.1 Gynecological Endoscopy Devices Hysteroscope Resectoscope Colposcope Laparoscope Endoscopic Imaging Systems
5.1.2 Endometrial Ablation Devices Balloon Ablation Devices Hydrothermal Ablation Devices Radiofrequency Ablation Devices Others
5.1.3 Contraceptive Devices Temporary Birth Control Permanent Birth Control
5.1.4 Diagnostic Imaging Systems
5.1.5 Fluid Management Systems
5.1.6 Others
5.2 Geography
5.2.1 North America United States Canada Mexico
5.2.2 Europe Germany United Kingdom France Italy Spain Rest of Europe
5.2.3 Asia-Pacific China Japan India Australia South Korea Rest of Asia-Pacific
5.2.4 Middle-East & Africa GCC South Africa Rest of Middle-East & Africa
5.2.5 South America Brazil Argentina Rest of South America

6.1 Company Profiles
6.1.1 Boston Scientific Corporation
6.1.2 Hologic, Inc.
6.1.3 Johnson & Johnson
6.1.4 Karl Storz SE & Co. KG
6.1.5 Medtronic PLC
6.1.6 Olympus Corporation
6.1.7 Richard Wolf GmbH
6.1.8 Stryker Corporation
6.1.9 The Cooper Companies, Inc.




Recommended reports